期刊文献+

不同类型血液灌流器联合血液透析对甲状旁腺激素的影响 被引量:3

下载PDF
导出
摘要 目的:对慢性肾功能衰竭(CRF)病人甲状旁腺激素(PTH)血清水平展开观察,分析不同血液灌流器类型+血液透析(HD)对PTH的影响以及清除效果。方法:选取2018-12~2019-12在齐齐哈尔市第一医院血液透析室进行维持血液透析治疗的90例患者,随机归入A组(行单纯血液透析治疗)、B组(行血液透析+树脂型血液灌流器治疗)与C组(行血液透析+活性炭型血液灌流器治疗),每组各30例。研究3个月,针对组内与3组间于未治疗时与3个月治疗结束时的PTH、血钙与血磷的血清水平展开对比分析。结果:就PTH而言,与未治疗时比较,3个月治疗结束时均下降(P<0.05),可见具备显著不同;在血钙水平,3组全部上升(P<0.05),即具有统计学价值;血磷全部下调(P<0.05),可见具有显著不同。与A组比较,B组和C组在PTH降低水平、血磷下降水平与血钙上升水平方面,均存在显著不同表现(P<0.05),即具有统计学价值,在上述3项指标上,对于B组与C组,不具有显著性(P>0.05)。结论:与单纯血液透析相比,血液透析(HD)与血液灌流(HP)的联合应用,能够更为显著地降低CRF患者PTH水平,同时对于钙磷代谢紊乱的改善效能更显著,而树脂型和活性炭型血液灌流器联合血液透析对甲状旁腺激素的影响无明显差异。
出处 《黑龙江医药科学》 2020年第2期59-60,62,共3页 Heilongjiang Medicine and Pharmacy
  • 相关文献

参考文献4

二级参考文献17

  • 1邵凤民,寇灵芝,程巧玲,李红菊,常淑莹,何丽君,范凯敏.连续性肾脏替代与间歇性血液透析治疗重症急性肾衰的比较研究[J].实用诊断与治疗杂志,2006,20(2):79-81. 被引量:26
  • 2陈香美,王海燕.提高慢性肾脏病的知晓率、治疗率和控制率减轻对国民健康的危害[J].中华内科杂志,2006,45(6):441-442. 被引量:65
  • 3Griveas I,Visvardis G,Fleva A,et al.Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis[J].Ren Fail,2005,27 (3):279-282.
  • 4Bammens B,Evenepoel P,Verbeke K,et al.Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms[J].Kidney Int,2003,64 (6):2238-2243.
  • 5Ates K,Nergizoglu G,Keven K,et al.Effect of fluid and sodium removal on mortality in peritoneal dialysis patients[J].Kidney Int,2001,60(2):767-776.
  • 6Wald R, Tentori F, Tighiouart H, et al. Impact of the KidneyDisease outcomes Quality Initiative (KDOQI) Clinical practice Guidelines for Bone Metabolism and Disease in a large dialysis network [ J ]. Am J Kidney Dis, 2007,49 (3) : 257 - 266.
  • 7Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcome and Practice PatternsStudy (DOPPS) [J]. Am J Kidney Dis, 2008,52(3): 519-530.
  • 8Raggi P, Boulay A, Taber Sc, et al. Cardiac calcification in adult hemodialysis patients a link between end-stage renal disease and cardiovascular disease [J]. J Am coll cardiol, 2002,39(4) :695-701.
  • 9Kimata N, Albert JM, Akiba T, et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study [J ]. Hemodial Int, 2007,11 (3) : 340-348.
  • 10Block GA, Klassen PS, Lazarus JM, et al. Mineral- metabolism, mortality, and morbidity in maintenance hemodial- ysis [J]. J Am Soc Nephrol, 2004,15(8):2208-2218.

共引文献308

同被引文献42

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部